Imaging of late infantile neuronal ceroid lipofuscinosis: A clinical rating scale

Neurology

Volumn 69, Issue 6, 2007, Pages 503-504

  Ramirez Montealegre, Denia ^b   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; INFANT DISEASE; NEUROIMAGING; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; CLASSIFICATION; DIAGNOSTIC IMAGING; GENETICS; HOSPITALIZATION; INFANT; NOTE; PATHOLOGY;

DIAGNOSTIC IMAGING; HUMANS; INFANT; NEURONAL CEROID-LIPOFUSCINOSES; SEVERITY OF ILLNESS INDEX;

EID: 34548398553     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000269663.23404.c5     Document Type: Editorial

References (9)

1. Perrault A, Oremus M, Demers L, Vida S, Wolfson C. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J Geriatr Psychiatry Neurol 2000;13:181-196.
2. Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington's disease. Huntington Study Group [erratum in 2000;54:1712]. Neurology 2000;54:452-458.
3. Santavuori P, Lauronen L, Kirveskari K, Aberg L, Sainio K. Neuronal ceroid lipofuscinoses in childhood. Suppl Clin Neurophysiol 2000;53:443-451.
4. Mole SE. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 2004; 14:70-76.
5. Ramirez-Montealegre D, Rothberg PG, Pearce DA. Another disorder finds its gene. Brain 2006;129(Pt 6):1353-1356.
6. Goebel HH, Mole SE, Lake BD. The neuronal ceroid lipofuscinoses (Batten disease). Amsterdam, Netherlands: IOS Press; 1999.
7. Marshall FJ, de Blieck EA, Mink JW, et al. A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology 2005;65:275-279.
8. Worgall S, Kekatpure MV, Heier L, et al. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. Neurology;69:521-535.
9. Steinfeld R, Heim P, von Gregory H, et al. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 2002;112:347-354.